2018
DOI: 10.4103/ijd.ijd_207_17
|View full text |Cite
|
Sign up to set email alerts
|

Study of S100 immunostaining in demonstrating neural granulomas in paucibacillary leprosy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
0
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 4 publications
0
0
0
Order By: Relevance
“…Because of the lack of studies investigating the neuropathic etiopathology of BMS, in particular using the S-100 protein, we also searched for parameters in studies on NF changes in other neuropathies, such as leprosy. 16,18 The S-100 protein has been suggested to be a superior strategy for the simultaneous identification of intact and fragmented nerve structures than H&E. 18 Furthermore, in leprosy cases, there is a 90.9% and 100% reduction of S-100 and PGP 9.5 immunoexpression for NF, respectively. These investigations also suggest that PGP 9.5 would be the best neuronal marker for the differentiation of intact nervous structures.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Because of the lack of studies investigating the neuropathic etiopathology of BMS, in particular using the S-100 protein, we also searched for parameters in studies on NF changes in other neuropathies, such as leprosy. 16,18 The S-100 protein has been suggested to be a superior strategy for the simultaneous identification of intact and fragmented nerve structures than H&E. 18 Furthermore, in leprosy cases, there is a 90.9% and 100% reduction of S-100 and PGP 9.5 immunoexpression for NF, respectively. These investigations also suggest that PGP 9.5 would be the best neuronal marker for the differentiation of intact nervous structures.…”
Section: Discussionmentioning
confidence: 99%
“…11 Neuronal proteins such as the gene product of protein 9.5 (PGP 9.5) and S-100 have been used to evaluate nerve structures in neuropathies. 6,13,[15][16][17][18] The hypothesis is that the early loss or nonexpression of PGP 9.5 seems to be associated with axonal degeneration processes, 15,17 as expected in neuropathies. PGP 9.5, a ubiquitin carboxydrolase, is expressed in axons and has been used to investigate neurodegenerative diseases.…”
Section: Introductionmentioning
confidence: 93%
See 1 more Smart Citation